OBJECTIVES: The expression of FOS, a gene critical for monocyte and macrophage function, can be inhibited by statins through the disruption of a cholesterol-independent signaling pathway. In this pilot study, we hypothesized that blood FOS mRNA levels will be sensitive to statin treatment independent of LDL cholesterol levels. METHODS: Three cohorts at increased risk of or with cardiovascular disease (CVD) were studied. Blood FOS mRNA levels were measured before and after statin treatment or in patients under stable treatment. RESULTS: Statin treatment for three months significantly reduced blood FOS mRNA and LDL cholesterol levels. However, in subjects with similar LDL levels achieved by different doses of long term statin treatment, there was an inverse relationship between statin dose and FOS expression. CONCLUSIONS: FOS mRNA levels appear to be a sensitive marker of statin treatment that is dissociated from cholesterol levels.
OBJECTIVES: The expression of FOS, a gene critical for monocyte and macrophage function, can be inhibited by statins through the disruption of a cholesterol-independent signaling pathway. In this pilot study, we hypothesized that blood FOS mRNA levels will be sensitive to statin treatment independent of LDL cholesterol levels. METHODS: Three cohorts at increased risk of or with cardiovascular disease (CVD) were studied. Blood FOS mRNA levels were measured before and after statin treatment or in patients under stable treatment. RESULTS: Statin treatment for three months significantly reduced blood FOS mRNA and LDL cholesterol levels. However, in subjects with similar LDL levels achieved by different doses of long term statin treatment, there was an inverse relationship between statin dose and FOS expression. CONCLUSIONS:FOS mRNA levels appear to be a sensitive marker of statin treatment that is dissociated from cholesterol levels.
Authors: Willmar D Patino; Omar Y Mian; Ju-Gyeong Kang; Satoaki Matoba; Linda D Bartlett; Brenda Holbrook; Hugh H Trout; Louis Kozloff; Paul M Hwang Journal: Proc Natl Acad Sci U S A Date: 2005-02-22 Impact factor: 11.205
Authors: Scott M Grundy; James I Cleeman; C Noel Bairey Merz; H Bryan Brewer; Luther T Clark; Donald B Hunninghake; Richard C Pasternak; Sidney C Smith; Neil J Stone Journal: Circulation Date: 2004-07-13 Impact factor: 29.690
Authors: Anna Maria Lavezzi; José Milei; Daniel R Grana; Federica Flenda; Aldo Basellini; Luigi Matturri Journal: Int J Cardiol Date: 2003-11 Impact factor: 4.164
Authors: Hong-Hee Won; Suk Ran Kim; Oh Young Bang; Sang-Chol Lee; Wooseong Huh; Jae-Wook Ko; Hyung-Gun Kim; Howard L McLeod; Thomas M O'Connell; Jong-Won Kim; Soo-Youn Lee Journal: J Mol Med (Berl) Date: 2011-09-24 Impact factor: 4.599
Authors: Alex M Ascensión; Mikel Arrospide-Elgarresta; Ander Izeta; Marcos J Araúzo-Bravo Journal: BMC Bioinformatics Date: 2017-06-06 Impact factor: 3.169